Co-Authors
This is a "connection" page, showing publications co-authored by Tarek Kashour and Imad Tleyjeh.
Connection Strength
9.682
-
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update. Clin Microbiol Infect. 2021 Aug; 27(8):1076-1082.
Score: 0.942
-
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis - Author's reply. Clin Microbiol Infect. 2021 08; 27(8):1177-1178.
Score: 0.933
-
Letter About: Risk Factors for Mortality in Patients with COVID-19 in New York City. J Gen Intern Med. 2021 03; 36(3):811-812.
Score: 0.923
-
Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility. Immunopharmacol Immunotoxicol. 2021 Feb; 43(1):37-50.
Score: 0.923
-
Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and the Risk of SARS-CoV-2 Infection or Hospitalization With COVID-19 Disease: A Systematic Review and Meta-Analysis. Am J Ther. 2020 Dec 28; 29(1):e74-e84.
Score: 0.921
-
Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Mortality Among COVID-19 Patients: A Systematic Review and Meta-Analysis. Am J Ther. 2020 Nov 10.
Score: 0.913
-
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis. Clin Microbiol Infect. 2021 Feb; 27(2):215-227.
Score: 0.912
-
Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis. Mayo Clin Proc Innov Qual Outcomes. 2021 Feb; 5(1):137-150.
Score: 0.911
-
It is time to drop hydroxychloroquine from our COVID-19 armamentarium. Med Hypotheses. 2020 Nov; 144:110198.
Score: 0.898
-
Overlooked Shortcomings of Observational Studies of Interventions in Coronavirus Disease 2019: An Illustrated Review for the Clinician. Open Forum Infect Dis. 2021 Aug; 8(8):ofab317.
Score: 0.238
-
Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19. Front Immunol. 2021; 12:686029.
Score: 0.238
-
Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis. Open Forum Infect Dis. 2021 Jul; 8(7):ofab284.
Score: 0.237
-
Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials. Clin Transl Sci. 2021 05; 14(3):1101-1112.
Score: 0.236
-
Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis. J Antimicrob Chemother. 2021 01 01; 76(1):30-42.
Score: 0.230
-
Association of corticosteroids use and outcomes in COVID-19 patients: A systematic review and meta-analysis. J Infect Public Health. 2020 Nov; 13(11):1652-1663.
Score: 0.226